Lifecycle Management

Vision, expertise and innovation for pharma product lifecycle management.

From early-stage development through commercial-stage manufacturing, we partner with you to define your product and market needs, develop the right solutions, and streamline your pharma product lifecycle management process to help efficiently commercialize your products faster.


For in-market drugs facing loss of exclusivity (LOE), Aprecia’s 3DP technology offers unique advantages for extending drug patent protection via 505(B)(2) submissions of patent-protected formulations.

Seize 3DP’s powerful drug patent extension opportunities with:

  • New formulations
  • New indications
  • New dose forms and loads
  • Combination drugs
  • Next-generation and future drugs
  • OTC switches

Open a New World of Market Possibilities

Aprecia’s 3DP for pharmaceutical manufacturing can help you expand your drug’s market reach into new therapeutic areas and patient populations by unlocking entirely new dosage forms – with formulation opportunities that can only be achieved using 3DP for Pharma technology.

Expand into new markets with:

  • New formulations
  • New indications
  • New patient populations
  • New dosage strength

Don Wetherhold

SVP, Business Development, Aprecia

“Pharmaceutical companies and their drugs face numerous challenges in the brief window between launch and patent expiration which make it important to plan lifecycle management (LCM) strategies well in advance of patent expiry. For pharmaceutical companies that seek market enhancements strategies beyond the capabilities of existing fast melt technologies, ZipDose technology offers an exclusive opportunity to address patient demand.”


Let's Get Started

Schedule a 3DP Discovery Assessment to learn how we can help you open new market opportunities with innovative dose forms.

Contact us at (513)

Try a free sample of our 3D printed ZipDose Technology ▸